Qin Yu, Yi Wei, Lin Shuxiong, Yang Chunfang, Zhuang Zemin
Clinical Medical College of Acupuncture-Moxibustion and Rehabilitation, Guangzhou University of CM, Guangzhou 510000, Guangdong Province, China.
Zhongguo Zhen Jiu. 2017 Dec 12;37(12):1265-8. doi: 10.13703/j.0255-2930.2017.12.003.
To compare the efficacy differences between abdominal acupuncture and western medication for diarrhea irritable bowel syndrome (IBS-D).
Sixty-one patients with IBS-D were randomly assigned into an acupuncture group (30 cases after 1 dropping) and a western medication group (28 cases after 2 dropping). Acupuncture was used at points [Zhongwan (CV 12), Xiawan (CV 10), Qihai (CV 6), Guanyuan (CV 4)], points [bilateral Huaroumen (ST 24), Wailing (ST 26)], point [bilateral Daheng (SP 15)], once every other day, 3 times a week. Pinaverium bromide tablet was used orally in the western medication group, 50 mg a time, 3 times a day. All the treatment was given for 4 weeks in the two groups. IBS symptom severity score (IBS-SSS) and clinical symptom scores for abdominal pain and distension, diarrhea, poor stool output, defecation urgency and stool abnormality were observed before and after the treatment as well as 3 months after treatment. Adverse reactions were recorded and the effects were evaluated.
①After treatment and at follow-up, the IBS-SSS scores of the two groups were lower than those before treatment (all <0.01). Compared with the western medication group, the scores and the improvements between the two time points and before treatment were better in the acupuncture group (<0.05, <0.01). ②The symptom scores in the two groups after treatment were lower than those before treatment including abdominal pain, abdominal distension, diarrhea, poor stool output, defecation urgency and stool abnormality (<0.05, <0.01), and the scores of abdominal pain, abdominal distension, diarrhea, poor stool output and stool abnormality in the acupuncture group were lower than those in the western medication group (<0.05, <0.01). ③The total effective rate and the cured and remarkable effective rate of the acupuncture group were higher than those of the western medication group [(86.7% (26/30) vs 64.3% (18/28), <0.05; 70.0% (21/30) vs 35.7% (10/28), <0.01)], and the therapeutic efficacy of the acupuncture group was better than that of the western medication group (<0.05). There was no adverse reaction.
Abdominal acupuncture is more effective for IBS-D than western medication and can relieve abdominal pain, abdominal distension, diarrhea, poor stool output, stool abnormality, with long-term effect.
比较腹针与西药治疗腹泻型肠易激综合征（IBS-D）的疗效差异。
将61例IBS-D患者随机分为针刺组（脱落1例后30例）和西药组（脱落2例后28例）。针刺选取穴位[中脘（CV 12）、下脘（CV 10）、气海（CV 6）、关元（CV 4）]、[双侧滑肉门（ST 24）、外陵（ST 26）]、[双侧大横（SP 15）]，隔日1次，每周3次。西药组口服匹维溴铵片，每次50 mg，每日3次。两组均治疗4周。观察治疗前、治疗后及治疗后3个月的IBS症状严重程度评分（IBS-SSS）以及腹痛腹胀、腹泻、排便不畅、排便急迫和大便异常的临床症状评分。记录不良反应并评估疗效。
①治疗后及随访时，两组IBS-SSS评分均低于治疗前（均P<0.01）。与西药组比较，针刺组两个时间点之间及与治疗前的评分及改善情况更好（P<0.05，P<0.01）。②两组治疗后症状评分均低于治疗前，包括腹痛、腹胀、腹泻、排便不畅、排便急迫和大便异常（P<0.05，P<0.01），且针刺组腹痛、腹胀、腹泻、排便不畅和大便异常评分低于西药组（P<0.05，P<0.01）。③针刺组总有效率及治愈显效率高于西药组[（86.7%（26/30）对64.3%（18/28），P<0.05；70.0%（21/30）对35.7%（10/28），P<0.01]，针刺组治疗效果优于西药组（P<0.05）。未出现不良反应。
腹针治疗IBS-D较西药更有效，能缓解腹痛、腹胀、腹泻、排便不畅、大便异常，且疗效持久。
